Search Results 41-50 of 16278 for Chronic Lymphocytic Leukemia
... lymphocytes. Previous research has shown that MBL is a precursor to a type of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL).
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small ...
... chronic lymphocytic leukemia (B-CLL). Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells ...
... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...
... Chronic Lymphocytic Leukemia. Print details. Share; Facebook · Twitter. Overview ... Diagnosis of Skin Cancer, with or without a CLL diagnosis. Exclusion ...
Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ...
... chronic lymphocytic leukemia. Monoclonal antibodies, such as rituximab, can ... chronic lymphocytic leukemia. Participation eligibility. Participant ...
... chronic lymphocytic leukemia that has returned or is resistant to treatment. Participation eligibility. Participant eligibility includes age, gender, type ...
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.